CCR5 and pancreatic ductal adenocarcinoma: Research by Delvecchio et al. (2021) indicated that intra-tumoral injection of CXCL13 and CCL21 recruited CCR5+ B cells and T cells into tumors, promoted TLS formation, and prolonged survival in pancreatic ductal adenocarcinoma mouse models.